Cytologic changes in two cervical carcinoma cell lines after transfection of the wild-type p53 gene

References

• Hollstein M, Sidransky D, Vogelstein B, Harris C C. p53 mutations in human cancers. Science 1991; 253: 49–53
   PubMed Web of Science ®Google Scholar
• Donehower L A, Bradley A. The tumor suppressor p53. Biochim Biophys Acta 1993; 1155: 181–205
   PubMed Web of Science ®Google Scholar
• Diller L, Kassel J, Nelson C E, Gryka M A, Litwak G, Gebhardt M. p53 functions as a cell cycle control protein in osteosarcomas. Mol Cell Biol 1990; 10: 5772–81
   PubMed Web of Science ®Google Scholar
• Velu T. Involvement of the p53 tumor suppressor gene in Phi-positive and Phi-negative myeloid leukemia. Blood 1990; 76: 1893–4
   PubMedGoogle Scholar
• Kern S E, Pietenpol J A, Thiagalingam S, Seymour A, Kinzler K W, Fogelstein B. Oncogenic forms of p53 inhibit p53- regulated gene expression. Science 1992; 256: 827–30
   PubMed Web of Science ®Google Scholar
• Ginsberg D, Mechta F, Yaniv M, Oren M. Wild-type p53 can down-modulate the activity of various promoters. Proc Natl Acad Sci USA 1991; 88: 9979–83
   PubMed Web of Science ®Google Scholar
• Santhanam U, Ray A, Sehgal P B. Repression of the interleukin 6 gene promoter by p53 and the retinoblastoma susceptibility gene product. Proc Natl Acad Sci USA 1991; 88: 7605–9
   PubMed Web of Science ®Google Scholar
• Momand J, Zambetti G P, Olson D C, George D, Levine A J. The mdm-2 oncogene product forms a complex with the p53 protein and inhibits p53-mediated transactivation. Cell 1992; 69: 1237–45
   PubMed Web of Science ®Google Scholar
• Howley P M. Role of human papillomaviruses in human cancer. Cancer Res 1991; 51: 5019s–22s
   PubMed Web of Science ®Google Scholar
• Vousden K. Interactions of human papillomavirus transforming proteins with the products of tumor suppressor genes. The FASEB Journal 1993; 7: 872–9
   PubMed Web of Science ®Google Scholar
• Crook T, Wrede D, Vousden K H. p53 point mutation in HPV negative human cervical carcinoma cell lines. Oncogene 1991; 6: 873–5
   PubMed Web of Science ®Google Scholar
• Scheffner M, Munger K, Byrne J C, Howley P M. The state of the p53 and retinoblastoma genes in human cervical carcinoma cell lines. Proc Natl Acad Sci USA 1991; 88: 5523–7
   PubMed Web of Science ®Google Scholar
• Iwasaka T, Oh-uchida M, Matsuo N, Yokoyama M, Fukuda K, Hara K. Correlation between HPV positivity and state of the p53 gene in cervical carcinoma cell lines. Gynecol Oncol 1993; 48: 104–9
   PubMed Web of Science ®Google Scholar
• Mercer W E, Shield M T, Amin M, Sauve G J, Appella E, Romano JW. Negative growth regulation in a glioblastoma tumor cell line that conditionally expresses human wild-type p53. Proc Natl Acad Sci USA 1990; 87: 6166–70
   PubMed Web of Science ®Google Scholar
• Casey G, Lo Hsueh M, Lopez M E, Vogelstein B, Stan-bridge EJ. Growth suppression of human breast cancer cells by the introduction of a wild-type p53 gene. Oncogene 1991; 6: 1791–7
   PubMed Web of Science ®Google Scholar
• Shaw P, Bovey R, Tardy S, Sordat B, Costa J. Induction of apoptosis by wild-type p53 in a human colon tumor-derived cell line. Proc Natl Acad Sci USA 1992; 89: 4495–9
   PubMed Web of Science ®Google Scholar
• Cheng J, Yee J K, Yeargin J, Friedmann T, Haas M. Suppression of acute lymphoblastic leukemia by the human wild-type p53 gene. Cancer Res 1992; 52: 222–6
   PubMed Web of Science ®Google Scholar
• Zheng P S, Iwasaka T, Ouchida M, Fukuda K, Yokoyama M, Sugimori H. Growth suppression of a cervical cancer cell line (TMCC-1) by the human wild type p53 gene. Gynecol Oncol 1996; 60: 245–50
   Google Scholar
• Sykes J A, Whitescarver J, Jernstrom P, Nolan J F, Byatt P. Some properties of a new epithelial cell line of human origin. JNCI 1970; 45: 107–22
   PubMed Web of Science ®Google Scholar
• Reuter S, Delius H, Kahn T, Hofmann B, Zur Hausen H, Sehwarz E. Characteristics of a novel human papillomavirus DNA in the cervical carcinoma cell line ME 180. J Virol 1991; 65: 5564–8
   Google Scholar
• Ginsberg D, Michalovitz D M, Oren M. Introduction of growth arrest by a temperature-sensitive p53 mutant is correlated with increased nuclear localization and decreased stability of the protein. Mol Cell Biol 1991; 11: 582–5
   PubMedGoogle Scholar
• Oren M. p53: the ultimate tumor suppressor gene. The FA-SEB J 1992; 6: 3169–76
   PubMed Web of Science ®Google Scholar
• Ryan J J, Danish R, Gottlieb C A, Clarke M F. Cell cycle analysis of p53-induced cell death in murine erythroleukemia cells. Mol Cell Biol 1993; 13: 711–9
   PubMed Web of Science ®Google Scholar
• Michalovitz D, Halevy O, Oren M. Conditional inhibition of transformation and of cell proliferation by a temperature- sensitive mutant of p53. Cell 1990; 62: 671–80
   PubMed Web of Science ®Google Scholar
• Yonish Rouach E, Resnitzky D, Lotem J, Sachs L, Kimchi A, Oren M. Wild-type p53 induces apoptosis of myeloid leukemia cells that is inhibited by interleukin 6. Nature 1991; 352: 345–7
   PubMed Web of Science ®Google Scholar
• Kastan M B, Onyekwere O, Sidransky D, Vogelstein B, Craig R W. Participation of p53 protein in the cellular response to DNA damage. Cancer Res 1991; 51: 6304–11
   PubMed Web of Science ®Google Scholar
• Vikhanskaya F, Erba E, D'Incalci M, Broggini M. Introduction of wild-type p53 in a human ovarian cancer cell line not expressing endogeneous p53. Nucleic Acids Res 1994; 22: 1012–7
   PubMed Web of Science ®Google Scholar
• Tauchi H, Sawada S. Analysis of mitotic cell death caused by radiation in mouse leukemia L5178Y cells: apoptosis is the ultimate form of cell death following mitotic failure. Int J Radiat Biol 1994; 65: 449–55
   PubMed Web of Science ®Google Scholar